Monthly Archives: February 2022

Multisystem Involvement in Post-Acute Sequelae of Coronavirus Disease 19 Posted on February 20, 2022 by admin

Novak P. et al., Multisystem Involvement in Post-Acute Sequelae of Coronavirus Disease 19.   Annals of Neurology 91(3): 367-379 (2022). https://doi.org/10.1002/ana.26286 https://onlinelibrary.wiley.com/doi/10.1002/ana.26286  

Posted in Uncategorized | Comments Off on Multisystem Involvement in Post-Acute Sequelae of Coronavirus Disease 19
Long covid, neuropsychiatric disorders, psychotropics, present and future Posted on February 11, 2022 by admin

Abstract Long-COVID refers to the lingering or protracted illness long after the acute illness. Depression, anxiety, fatigue, concentration and cognitive impairment appeared to be reported often in long COVID, psychosis seemed uncommon. Neuropsychiatric disorders in long COVID could be a … Continue reading →

Posted in Uncategorized | Comments Off on Long covid, neuropsychiatric disorders, psychotropics, present and future
Strong evidence that Epstein–Barr virus infection triggers multiple sclerosis Posted on February 10, 2022 by admin

Welberg, L. Strong evidence that Epstein–Barr virus infection triggers multiple sclerosis. Nat Neurosci 25, 131 (2022). https://doi.org/10.1038/s41593-022-01017-5 https://doi.org/10.1126/science.abj8222 (2022)

Posted in Uncategorized | Comments Off on Strong evidence that Epstein–Barr virus infection triggers multiple sclerosis
Clonally Expanded B Cells in Multiple Sclerosis Bind EBV EBNA1 and GlialCAM Posted on February 2, 2022 by admin

Abbrev. Abstract: Multiple sclerosis (MS) is a heterogenous autoimmune disease in which autoreactive lymphocytes attack the myelin sheath of the central nervous system (CNS). B lymphocytes in the cerebrospinal fluid (CSF) of MS patients contribute to inflammation and secrete oligoclonal … Continue reading →

Posted in Uncategorized | Comments Off on Clonally Expanded B Cells in Multiple Sclerosis Bind EBV EBNA1 and GlialCAM